Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 0.57 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.57 |
| ▸ | PIM3 | Q86V86 | 9/20 | 0.52 |
| ▸ | PIM1 | P11309 | 7/20 | 0.52 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | DNA2 | P51530 | 1/20 | 0.40 |
| ▸ | CASP6 | P55212 | 1/20 | 0.40 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.40 |
| ▸ | ERN1 | O75460 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3056048 | 0.84 | TRIM24 (0.57) | TRIM24TRIM33PIM3PIM1PIM2 | |
| SCHEMBL29955386 | 0.78 | TRIM24 (0.66) | TRIM24TRIM33PIM3PIM1PIM2 | |
| SCHEMBL29954763 | 0.77 | TRIM24 (0.70) | TRIM24TRIM33PIM3PIM1PIM2 | |
| SCHEMBL29953184 | 0.76 | PIM3 (0.77) | TRIM24TRIM33PIM3PIM1PIM2 | |
| SCHEMBL16067373 | 0.76 | PIM3 (0.77) | TRIM24TRIM33PIM3PIM1PIM2 | |
| SCHEMBL1092989 | 0.73 | TRIM24 (0.64) | TRIM24TRIM33PIM3PIM1PIM2 | |
| SCHEMBL672635 | 0.73 | TRIM24 (1.00) | TRIM24TRIM33PIM3PIM1PIM2 | |
| SCHEMBL29954012 | 0.73 | TRIM24 (0.64) | TRIM24TRIM33PIM3PIM1PIM2 | |
| SCHEMBL670824 | 0.73 | TRIM24 (0.64) | TRIM24TRIM33PIM3PIM1PIM2 | |
| SCHEMBL14519078 | 0.72 | PIM3 (0.65) | TRIM24TRIM33PIM3PIM1PIM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7723374-B2 | PPAR active compounds | PLEXXIKON, INC. (US) | 2010-05-25 | — | — | US | disclosed |
| US-20070155818-A1 | PPAR ACTIVE COMPOUNDS | PLEXXIKON, INC. | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070155818-A1 | PPAR ACTIVE COMPOUNDS | PPARG, PPARD, PPARA | TRIM24 2245/4885TRIM33 3486/4885PIM3 4439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.